Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3324/haematol.2015.139337

http://scihub22266oqcxt.onion/10.3324/haematol.2015.139337
suck pdf from google scholar
C5004358!5004358 !27132280
unlimited free pdf from europmc27132280
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27132280 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27132280 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27132280
      Haematologica 2016 ; 101 (5 ): 541-58
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Chronic myeloid leukemia: reminiscences and dreams #MMPMID27132280
  • Mughal TI ; Radich JP ; Deininger MW ; Apperley JF ; Hughes TP ; Harrison CJ ; Gambacorti-Passerini C ; Saglio G ; Cortes J ; Daley GQ
  • Haematologica 2016[May]; 101 (5 ): 541-58 PMID27132280 show ga
  • With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman originally made seminal contributions to the use of autologous and allogeneic stem cell transplantation from the late 1970s onwards. Then, in collaboration with Brian Druker, he led efforts to develop ABL1 tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia in the late 1990s. He also led the global efforts to develop and harmonize methodology for molecular monitoring, and was an indefatigable organizer of international conferences. These conferences brought together clinicians and scientists, and accelerated the adoption of new therapies. The abundance of praise, tributes and testimonies expressed by many serve to illustrate the indelible impressions these two passionate and affable scholars made on so many people's lives. This tribute provides an outline of the remarkable story of chronic myeloid leukemia, and in writing it, it is clear that the historical triumph of biomedical science over this leukemia cannot be considered without appreciating the work of both Janet Rowley and John Goldman.
  • |Antineoplastic Agents/chemistry/pharmacology/therapeutic use [MESH]
  • |Cytogenetic Analysis/history/methods [MESH]
  • |Fusion Proteins, bcr-abl/antagonists & inhibitors/chemistry/genetics [MESH]
  • |History, 20th Century [MESH]
  • |Humans [MESH]
  • |Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/*drug therapy/*genetics/mortality [MESH]
  • |Molecular Targeted Therapy/history/methods [MESH]
  • |Mutation [MESH]
  • |Philadelphia Chromosome [MESH]
  • |Prognosis [MESH]
  • |Protein Kinase Inhibitors/chemistry/pharmacology/therapeutic use [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box